View Item 

Show simple item record

Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis
dc.contributor.authorSimmons, O.
dc.contributor.authorFetzer, D. T.
dc.contributor.authorYokoo, T.
dc.contributor.authorMarrero, J. A.
dc.contributor.authorYopp, A.
dc.contributor.authorKono, Y.
dc.contributor.authorParikh, N. D.
dc.contributor.authorBrowning, T.
dc.contributor.authorSingal, A. G.
dc.date.accessioned2017-01-10T19:03:32Z
dc.date.available2018-03-01T16:43:50Zen
dc.date.issued2017-01
dc.identifier.citationSimmons, O.; Fetzer, D. T.; Yokoo, T.; Marrero, J. A.; Yopp, A.; Kono, Y.; Parikh, N. D.; Browning, T.; Singal, A. G. (2017). "Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis." Alimentary Pharmacology & Therapeutics (1): 169-177.
dc.identifier.issn0269-2813
dc.identifier.issn1365-2036
dc.identifier.urihttps://hdl.handle.net/2027.42/135189
dc.publisherWiley Periodicals, Inc.
dc.titlePredictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPharmacy and Pharmacology
dc.subject.hlbsecondlevelOtolaryngology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/135189/1/apt13841_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/135189/2/apt13841.pdf
dc.identifier.doi10.1111/apt.13841
dc.identifier.sourceAlimentary Pharmacology & Therapeutics
dc.identifier.citedreferenceSanyal AJNASH. A global health problem. Hepatol Res 2011; 41: 670 – 4.
dc.identifier.citedreferenceBruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona‐2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421 – 30.
dc.identifier.citedreferenceSingal A, Volk ML, Waljee A, et al. Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 2009; 30: 37 – 47.
dc.identifier.citedreferenceSingal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta‐analysis. PLoS Med 2014; 11: e1001624.
dc.identifier.citedreferenceTrevisani F, De NS, Rapaccini G, et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 2002; 97: 734 – 44.
dc.identifier.citedreferencevan Meer S, de Man RA, Coenraad MJ, et al. Surveillance for hepatocellular carcinoma is associated with increased survival: results from a large cohort in the Netherlands. J Hepatol 2015; 63: 1156 – 63.
dc.identifier.citedreferenceSingal AG, Conjeevaram HS, Volk ML, et al. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev 2012; 21: 793 – 9.
dc.identifier.citedreferenceSingal AG, Nehra M, Adams‐Huet B, et al. Detection of hepatocellular carcinoma at advanced stages among patients in the HALT‐C trial: where did surveillance fail? Am J Gastroenterol 2013; 108: 425 – 32.
dc.identifier.citedreferenceFinberg HJ. Whither (wither?) the ultrasound specialist? J Ultrasound Med 2004; 23: 1543 – 7.
dc.identifier.citedreferenceAndersson KL, Salomon JA, Goldie SJ, Chung RT. Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2008; 6: 1418 – 24.
dc.identifier.citedreferenceBrenner DJ, Hall EJ. Computed tomography–an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277 – 84.
dc.identifier.citedreferenceYopp AC, Mansour JC, Beg MS, et al. Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol 2014; 21: 1287 – 95.
dc.identifier.citedreferenceLlovet JM, Ducreaux M, Lencioni R, et al. EASL‐EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908 – 43.
dc.identifier.citedreferenceDel Poggio P, Olmi S, Ciccarese F, et al. Factors that affect efficacy of ultrasound surveillance for early‐stage hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2014; 12: 1927 – 33.
dc.identifier.citedreferenceKhalili K, Menezes R, Kim TY, Yazdi LK, et al. The effectiveness of ultrasound surveillance for hepatocellular carcinoma in a Canadian centre and determinants of its success. Can J Gastroenterol Hepatol 2015; 29: 267 – 73.
dc.identifier.citedreferenceUppot RN, Sahani DV, Hahn PF, Kalra MK, Saini SS, Mueller PR. Effect of obesity on image quality: fifteen‐year longitudinal study for evaluation of dictated radiology reports. Radiology 2006; 240: 435 – 9.
dc.identifier.citedreferenceTchelepi H, Ralls PW, Radin R, Grant E. Sonography of diffuse liver disease. J Ultrasound Med 2002; 21: 1023 – 32; quiz 1033–4.
dc.identifier.citedreferenceEl‐Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142: 1264 – 73 e1.
dc.identifier.citedreferenceSingal AG, Mukherjee A, Joseph Elmunzer B, et al. Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinoma. Am J Gastroenterol 2013; 108: 1723 – 30.
dc.identifier.citedreferenceMarrero JA, El‐Serag HB. Alpha‐fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases. Hepatology 2011; 53: 1060 – 1; author reply 1061–2.
dc.identifier.citedreferenceGopal P, Yopp AC, Waljee AK, et al. Factors that affect accuracy of alpha‐fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2014; 12: 870 – 7.
dc.identifier.citedreferenceMarrero JA, Feng Z, Wang Y, et al. Alpha‐fetoprotein, des‐gamma carboxyprothrombin, and lectin‐bound alpha‐fetoprotein in early hepatocellular carcinoma. Gastroenterology 2009; 137: 110 – 8.
dc.identifier.citedreferenceBruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2010; 53: 1 – 35.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
apt13841_am.pdf
Size:
145.7KB
Format:
PDF
View/Open
Name:
apt13841.pdf
Size:
229.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.